An Activist Hedge Fund Manager Thinks This $100 Billion Biotech Company Could Be Worth 80% More (AMGN)

Business Insider Oct 21 2014 BoardNews

Dan Loeb thinks Amgen could be worth $249 per share, or 80% more than current levels. In his latest filing with the SEC, Loeb's Third Point was shown to be holding 450,000 shares of the company...

Read Full Article

Bookmark or Share this article

Login to comment.

Trading in Shares of the Light Bulb Company Whose Chairman Was Arrested Will Be Suspended for at Least a Few More Weeks (FNRG) also written by Myles Udland
Warren Buffett's 50th letter to Berkshire Shareholders (DIA, Spy, Spx, Brk) also written by Myles Udland
Germany's Corporate Governance Problem also categorized in BoardNews
Why Should We Care About Corporate Interlocks? also categorized in BoardNews
Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
The Other Duty of Corporate Governance also categorized in BoardNews
GMI Ratings Update | Duke Energy Corporation also published in Business Insider
Here is GE's Big Presentation Explaining How and Why it is Breaking Itself Up (GE) also written by Myles Udland
Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
Jamie Dimon is a Billionaire (JPM) also written by Myles Udland

An Activist Hedge Fund Manager Thinks This $100 Billion Biotech Company Could Be Worth 80% More (AMGN)

Login to comment.

Related Articles

Topics Mentioned

Authors

An Activist Hedge Fund Manager Thinks This $100 Billion Biotech Company Could Be Worth 80% More (AMGN)

Login to comment.

Related Articles

Categories

BoardProspects Features:

Topics Mentioned

Authors